Haliloglu Belma, Bereket Abdullah
J Pediatr Endocrinol Metab. 2015 May;28(5-6):503-13. doi: 10.1515/jpem-2014-0512.
Hypothalamic obesity (HyOb) is a complex neuroendocrine disorder caused by damage to the hypothalamus, which results in disruption of energy regulation. The key hypothalamic areas of energy regulation are the ARC (arcuate nucleus), the VMH (ventromedial hypothalamus), the PVN (paraventriculer nuclei) and the LHA (lateral hypothalamic area). These pathways can be disrupted mechanically by hypothalamic tumors, neurosurgery, inflammatory disorders, radiotherapy and trauma or functionally as such seen in genetic diseases. Rapid weight gain and severe obesity are the most striking features of HyOb and caused by hyperphagia, reduced basal metabolic rate (BMR) and decreased physical activity. HyOb is usually unresponsive to diet and exercise. Although, GLP-1 and its anologs seem to be a new agent, there is still no curative treatment. Thus, prevention is of prime importance and the clinicians should be alert and vigilant in patients at risk for development of HyOb.
下丘脑性肥胖(HyOb)是一种由下丘脑损伤引起的复杂神经内分泌疾病,导致能量调节紊乱。能量调节的关键下丘脑区域是弓状核(ARC)、腹内侧下丘脑(VMH)、室旁核(PVN)和外侧下丘脑区(LHA)。这些通路可因下丘脑肿瘤、神经外科手术、炎症性疾病、放疗和创伤而受到机械性破坏,或在遗传性疾病中出现功能性破坏。体重快速增加和严重肥胖是HyOb最显著的特征,由食欲亢进、基础代谢率(BMR)降低和身体活动减少引起。HyOb通常对饮食和运动无反应。尽管胰高血糖素样肽-1(GLP-1)及其类似物似乎是一种新的治疗药物,但仍没有治愈方法。因此,预防至关重要,临床医生应对有发生HyOb风险的患者保持警惕。